Novel amidino substituted 2-phenylbenzothiazoles: synthesis, antitumor evaluation in vitro and acute toxicity testing in vivo. 2010

Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
Department of Applied Chemistry, Faculty of Textile Technology, University of Zagreb, baruna Filipovića 10000 Zagreb, Croatia.

The efficient synthesis of new bis-substituted nitro-amidino, amino-amidino (10a, 10b-13a, 13b) and previously prepared diamidino 2-phenyl-benzothiazoles (9a, 9b) is described. The compounds 11a and 11b were prepared by recently developed methodology of the key precursors in zwitterionic form 8a and 8b with 4-nitrobenzoylchloride in a very good yield (70%). All compounds except diamidino-substituted 2-phenylbenzothiazole 9a show exceptionally prominent tumor cell-growth inhibitory activity and cytotoxicity, whereby the special selectivity of amino-amidine 2-phenylbenzothiazole 12a towards MCF-7 and H 460 cells makes this compound a prospective lead compound that should be further evaluated in animal models. All in vivo tested compounds (12a, 12b, 13a and 13b) are absorbed from mice gastrointestinal system. LD(50) are between 67.33 and 696.2mg/kg body weight (OECD/EPA toxicity categories 2-3).

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
May 2006, Molecules (Basel, Switzerland),
Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
July 2007, Bioorganic & medicinal chemistry,
Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
January 2017, Anti-cancer agents in medicinal chemistry,
Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
May 2014, Archives of pharmacal research,
Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
November 2007, Journal of medicinal chemistry,
Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
April 2014, Die Pharmazie,
Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
October 2010, Journal of medicinal chemistry,
Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
January 2015, Journal of enzyme inhibition and medicinal chemistry,
Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
December 2022, International journal of molecular sciences,
Livio Racané, and Marijeta Kralj, and Lidija Suman, and Ranko Stojković, and Vesna Tralić-Kulenović, and Grace Karminski-Zamola
August 2006, Molecules (Basel, Switzerland),
Copied contents to your clipboard!